XML 30 R10.htm IDEA: XBRL DOCUMENT v3.19.3
Intangible Assets, Net
 9 Months Ended
Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net
Intangible Assets, Net
At September 30, 2019, the Company’s intangible assets, net, consisted of the following:
 
Useful
Life
(Years)
 
Gross
September 30,
2019
 
Accumulated
Amortization
 
Net
September 30,
2019
Indefinite lived assets:
 
 
 
 
 
 
 
Medicare license
N/A
 
$
—

 
$
—

 
$
—

Amortized intangible assets:
 
 
 
 
 
 
 
Network relationships
11-15
 
151,152,000

 
(57,503,773
)
 
93,648,227

Management contracts
15
 
22,832,000

 
(9,146,391
)
 
13,685,609

Member relationships
12
 
6,696,000

 
(2,086,523
)
 
4,609,477

Patient management platform
5
 
2,060,000

 
(755,333
)
 
1,304,667

Tradename/trademarks
20
 
1,011,000

 
(92,675
)
 
918,325

 
 
 
$
183,751,000

 
$
(69,584,695
)
 
$
114,166,305

At December 31, 2018, the Company’s intangible assets, net, consisted of the following:
 
Useful
Life
(Years)
 
Gross
December 31,
2018
 
Accumulated
Amortization
 
Net
December 31,
2018
Indefinite lived assets:
 
 
 
 
 
 
 
Medicare license
N/A
 
$
1,994,000

 
$
—

 
$
1,994,000

Amortized intangible assets:
 
 
 
 
 
 
 
Network relationships
11-15
 
109,883,000

 
(48,361,773
)
 
61,521,227

Management contracts
15
 
22,832,000

 
(7,447,581
)
 
15,384,419

Member relationships
12
 
6,696,000

 
(1,289,667
)
 
5,406,333

Patient management platform
5
 
2,060,000

 
(446,333
)
 
1,613,667

Tradename/trademarks
20
 
1,011,000

 
(54,763
)
 
956,237

 
 
 
$
144,476,000

 
$
(57,600,117
)
 
$
86,875,883


Included in depreciation and amortization on the accompanying condensed consolidated statements of income is amortization expense of $4.3 million and $4.2 million (excluding $0.1 million of amortization expense for exclusivity incentives) for the three months ended September 30, 2019 and 2018, respectively, and $12.0 million and $12.8 million (excluding $0.3 million of amortization expense for exclusivity incentives) for the nine months ended September 30, 2019 and 2018, respectively.
During the three and nine months ended September 30, 2019, the Company wrote off indefinite-lived intangible assets of $2.0 million related to Medicare licenses it acquired as part of the Merger. The Company will no longer utilize these licenses and as such the Company will not receive future economic benefits.
Future amortization expense is estimated to be as follows for the following years ending December 31:
 
Amount
 
 
2019 (excluding the nine months ended September 30, 2019)
$
4,212,000

2020
15,757,000

2021
14,436,000

2022
13,559,000

2023
12,341,000

Thereafter
53,861,000

 
 
Total
$
114,166,000